Equities

VG Life Sciences Inc

VGLS:PKC

VG Life Sciences Inc

Actions
  • Price (USD)0.0001
  • Today's Change0.00 / 0.00%
  • Shares traded1.01m
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 20:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

VG Life Sciences Inc. is engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. The Company has not generated any revenue.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.30m
  • Incorporated1998
  • Employees7.00
  • Location
    VG Life Sciences IncPO Box 1020SOUTH PASADENA 91031United StatesUSA
  • Phone+1 (805) 879-9000
  • Fax+1 (302) 655-5049
  • Websitehttp://www.vglifesciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hi-Great Group Holding Co71.99k-74.35k1.78m--------24.73-0.0007-0.00070.0007-0.00130.71490.627-----73.83------51.28---103.28--0.0099-20.74-----47.32---3,789.70------
Axim Biotechnologies Inc92.90k-4.14m1.81m6.00------19.50-0.0163-0.01630.0003-0.03240.0233----15,483.33-103.73-154.34---390.7316.94---4,451.97-36,362.71---3.14----345.05-27.38-29.10------
Pharmagreen Biotech Inc1.56k-500.66k1.92m0.00------1,233.70-0.0011-0.00110.00-0.00450.0094--3.35---302.10-472.20----11.54---32,096.15--0.0194-71.71--------80.68------
Cyclacel Pharmaceuticals Inc80.00k-17.61m1.93m12.00--1.77--24.18-16.14-16.140.04230.55340.0065--0.0547---142.14-57.58-327.21-69.81-----21,882.50-18,789.29---100.520.00----22.87-6.34---31.23--
Novelstem International Corp18.00k-1.65m1.97m15.00------109.39-0.0352-0.03520.0004-0.05410.0081--8.00---63.77-----------7,867.33-----2.132.61--0.00---446.84------
180 Life Sciences Corp0.00-12.55m2.02m4.00---------28.16-28.160.00-0.44390.00----0.00-142.80-42.39-270.23-56.41------------18.20------48.52------
VG Life Sciences Inc0.00-4.30m2.11m7.00---------0.0721-0.07210.00-0.04910.00-------384.41-294.08-----------587,591.90---1.70--------16.58------
Kiromic Biopharma Inc0.00-26.21m2.20m35.00---------19.73-19.730.00-3.350.00----0.00-167.49-161.04---294.57-----------7.221.74------33.00--8.52--
Zyversa Therapeutics Inc0.00-21.86m2.26m7.00--0.2131-----100.63-100.630.0010.320.00----0.00-84.85---140.95-------------21,828.740.00-------340.15------
Bio Path Holdings Inc0.00-11.60m2.27m10.00--1.58-----17.91-17.910.000.56550.00----0.00-199.23-70.80-321.87-76.87------------0.00-------15.94------
Aptevo Therapeutics Inc0.00-25.25m2.29m40.00--0.1555-----46.21-45.630.001.090.00----0.00-115.20-47.16-160.28-85.03-------583.47----0.00---100.00---365.90------
Dermata Therapeutics Inc0.00-9.82m2.34m8.00--0.3719-----19.42-19.420.004.790.00----0.00-140.74---173.01--------------0.00------18.90------
Bluejay Diagnostics Inc0.00-9.40m2.35m10.00--0.0425-----44.53-44.530.003.340.00----0.00-97.27---121.76-------------19.610.0185---100.00---7.07------
Salarius Pharmaceuticals Inc0.00-6.46m2.46m2.00--0.4616-----12.64-12.640.003.700.00----0.00-82.83-69.27-119.83-79.89-------675.70----0.00------60.32------
Data as of Sep 20 2024. Currency figures normalised to VG Life Sciences Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.